Min Li to Immunotherapy
This is a "connection" page, showing publications Min Li has written about Immunotherapy.
Connection Strength
1.704
-
A subset of epithelial cells mimics regulatory T cells and contributes to immune evasion during development of pancreatic adenocarcinoma. BMC Med. 2020 06 29; 18(1):155.
Score: 0.636
-
Editorial - Special issue on Fighting Pancreatic Cancer. Cancer Lett. 2017 07 10; 398:22-23.
Score: 0.509
-
Localized ablative immunotherapy enhances antitumor immunity by modulating the transcriptome of tumor-infiltrating Gamma delta T cells. Cancer Lett. 2024 Nov 01; 604:217267.
Score: 0.213
-
EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy. Biochim Biophys Acta Rev Cancer. 2022 03; 1877(2):188700.
Score: 0.178
-
An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer. EBioMedicine. 2021 Mar; 65:103271.
Score: 0.167